Poststroke thalamic pain
Conditions
Interventions
study group:Oral Ruyi Zhenbao Pills
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for thalamic pain after stroke in Western medicine and stroke in traditional Chinese medicine; (2) Able to cooperate in completing physical examinations, laboratory tests, and scale evaluations; (3) Between the ages of 18 and 80; (4) First time stroke patients; (5) Poststroke thalamic pain course = 6 months; (6) Visual Analog Scale (VAS) = 4 points, Pain Rating Index (PRI) = 10 points, Current Pain Intensity (PPI) = 2 points; (7) Gender unlimited; (8) The subjects have informed consent and voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who have been confirmed to have combined diseases such as brain trauma, brain tumors, and brain parasitic diseases through examination; (2) Individuals who have previously suffered from chronic or serious diseases of the digestive, respiratory, urinary, blood, and reproductive systems, and are deemed unsuitable by the researchers to participate in this clinical trial; (3) Patients with severe liver and kidney diseases or abnormal liver and kidney function tests (ALT, AST = 1.5 times the upper limit of normal, Cr>the upper limit of normal); (4) Merge individuals with pain caused by other reasons; (5) Merge other disease patients who need to take drugs with similar therapeutic functions as the experimental drug; (6) Those who require routine use of opioid drugs; (7) Other comorbidities and complications that may affect drug evaluation include epilepsy, cognitive impairment, consciousness impairment, intellectual impairment, severe anxiety, severe depression, and severe physical disorders; (8) Individuals who are known or suspected to be allergic to this medication or to multiple medications; (9) Those who suspect or have a history of alcohol or drug abuse; (10) Pregnant, lactating women or those with recent fertility plans; (11) Individuals who have participated in other clinical trials within the first three months of selection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short-Form McGill Pain Questionnaire;Dosage of painkillers used; | — |
Secondary
| Measure | Time frame |
|---|---|
| Short-Form 36 Questionnaire; | — |
Countries
China
Contacts
Public ContactZhou Li
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed